metricas
covid
Annals of Hepatology EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS P...
Journal Information

Statistics

Follow this link to access the full text of the article

#128
EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS PREVIOUSLY TREATED WITH FIBRATES OR OBETICHOLIC ACID
Alejandra M. Villamil1, Daniel Pratt2, Andreas E. Kremer3, Vincenza Calvaruso4, Elena Gómez Dominguez5, Xin Qi6, Sarah Proehl6, William T. Barchuk6, Timothy R. Watkins6, Stuart C. Gordon7
1 The Liver Autoimmunity Unit. Hospital Italiano de Buenos Aires, Argentina.
2 Autoimmune and Cholestatic Liver Center. Massachusetts General Hospital, USA.
3 Department of Gastroenterology and Hepatology. University Hospital Zürich. University of Zürich, Switzerland.
4 Gastroenterology and Hepatology Unit. University of Palermo, Italia.
5 Hepatology Unit. University Hospital 12 de Octubre, España.
6 Gilead Sciences, Inc, USA.
7 Division of Hepatology. Henry Ford Hospital. Wayne State University School of Medicine and Michigan State University College of Medicine, USA.
Read
174
Times
was read the article
66
Total PDF
108
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 10 3 13
2025 11 48 43 91
2025 10 42 16 58
2025 9 8 4 12

Follow this link to access the full text of the article